* Prestige Consumer Healthcare Inc PBH.N reported
quarterly
adjusted earnings of $1.09 per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of $1.07. The mean expectation of
seven analysts for the quarter was for earnings of $1.08 per
share. Wall Street expected results to range from $1.08
to $1.10 per share.
* Revenue fell 0.9% to $283.79 million from a year ago;
analysts
expected $282.09 million.
* Prestige Consumer Healthcare Inc's reported EPS for the
quarter
was $1.09.
* The company reported quarterly net income of $54.38
million.
* Prestige Consumer Healthcare Inc shares had risen by 7.7%
this
quarter and gained 26.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 0.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Prestige Consumer
Healthcare Inc is $81.00
This summary was machine generated from LSEG data November 7 at
02:42 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 1.08 1.09 Beat
Jun. 30 2024 0.86 0.90 Beat
Mar. 31 2024 1.14 0.98 Missed
Dec. 31 2023 1.06